Table 1 Study characteristics
Study | Country | Cancer type | Number of participants | Age, mean (SD) | Sex (% female) | Inclusion criteria | Study design | Data collection | ||
|---|---|---|---|---|---|---|---|---|---|---|
Demographic and clinical information | Actigraph accelerometer | Fatigue | ||||||||
Boyle, 2016 [16] | Australia | Breast | 252 | 60.4 (10.5) | 100 | - Being female - Aged 18–80 years of age at time of diagnosis - Being 1–3 years post-diagnosis - Residing in Western-Australia at time of diagnosis - Not diagnosed with another cancer - Completed cancer treatment | Cross-sectional | Self-report | GT3X-Plus | FACT-Fatigue |
Boyle, 2017 [17] | Australia | Non-Hodgkin lymphoma | 156 | 62.5 (12.8) | 47.7 | - Histologically confirmed NHL diagnosis - Residing in Western-Australia at time of study - Not diagnosed with another cancer - Completed cancer treatment | Cross-sectional | Self-report | GT3X | FACT-Fatigue |
D’Silva, 2018 [27] | Canada | Lung | 121 | 71.2 (8.9) | 57.0 | - Previous clinical and/or pathological diagnosis of NSCLC - Not currently receiving any treatment for lung cancer or any other cancer - Not living in a hospice or long-term care - Age ≥ 18 years - Ability to read and write English | Cross-sectional | Self-report (co-morbidities, smoking status, demographic characteristics) and Glans-Look Lung Cancer Database (clinical characteristics) | GT3X-Plus | FACT-Fatigue |
Kampshoff, 2015 [24] | The Netherlands | Mixed | 232 | 54.1 (10.9) | 79.7 | - Histologically confirmed breast, colon, ovarian, cervix or testis cancer or lymphomas - No indication of recurrent or progressive disease - Aged ≥18 years - Able to perform basic activities of daily living - No cognitive disorders of severe emotional instability - No other serious disease that might hamper patients’ ability to carry out exercise - Ability to understand the Dutch language | Multicentre RCT (Baseline data; 4–6 weeks after completion of primary treatment) | Self-report (socio-demographic variables) and medical records (clinical characteristics) | Actitrainer | MFI |
Persoon, 2017 [25] | The Netherlands | Haematological | 82 | 52.7 (10.1) | 37.8 | - Treated with auto-stem cell transplantation for multiple myeloma or lymphoma, - Able to undergo exercise testing and participate in an exercise intervention | Multicenter RCT (Baseline data; 6–14 weeks after transplantation) | Self-report (socio-demographic characteristics) and medical records (clinical characteristics) | Actitrainer | MFI |
Phillips, 2015 [28] | United States | Breast | 412 | 56.7 (9.2) | 100 | - Age ≥ 18 years - Prior breast cancer history - English-speaking - Access to the Internet | Prospective longitudinal study (Baseline data from a subset of patients who participated in an on-line questionnaire study) | Self-report | GT1M | FSI |
Vallance, 2015 [26] | Australia/ Canada | Colon | 156 | 64.5 (9.8) | 48.7 | - Histologically confirmed stage I-III colon cancer - Aged 18–80 years of age - Completed cancer treatment - English speaking | Cross-sectional | Self-report | GT3X-Plus | FACT-Fatigue |
Van Waart, 2017 [23] | The Netherlands | Breast/ colon | 36 | 52.9 (8.7) | 97.2 | - Histologically confirmed primary breast or colon cancer - No orthopaedic, cardiovascular or cardiopulmonary conditions - Not suffering from malnutrition, serious psychiatric or cognitive problems - Ability to understand the Dutch language | Multicentre RCT (Follow up data from patients randomized to the control group) | Self-report (socio-demographic variables) and medical records (clinical characteristics) | Actitrainer | MFI |